Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Figg

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Journal of Chromatography|February 11, 1994
Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasmaW D Figg, H J Yeh, A Thibault, et al.
Pharmacotherapy|January 1, 1997
The pharmacokinetics of TNP-470, a new angiogenesis inhibitorW D Figg, J M Pluda, R M Lush, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Suramin-induced neutropeniaN A Dawson, R M Lush, S M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxelM H Kang, W D Figg, Y Ando, et al.
Thescientificworldjournal|February 25, 2014
Angiogenesis in spontaneous tumors and implications for comparative tumor biologyC Benazzi, A Al-Dissi, C H Chau, et al.
Cancer Investigation|January 1, 1996
Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancerW D Figg, K Ammerman, N Patronas, et al.
Pharmacotherapy|December 17, 1998
Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virusS C Piscitelli, S Vogel, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanismsH R Alexander, C K Brown, D L Bartlett, et al.
Cancer|September 1, 1994
Acute renal toxicity associated with suramin in the treatment of prostate cancerW D Figg, M R Cooper, A Thibault, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamineS C Piscitelli, A Thibault, W D Figg, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Journal of Chromatography|February 11, 1994
Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasmaW D Figg, H J Yeh, A Thibault, et al.
Pharmacotherapy|January 1, 1997
The pharmacokinetics of TNP-470, a new angiogenesis inhibitorW D Figg, J M Pluda, R M Lush, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Suramin-induced neutropeniaN A Dawson, R M Lush, S M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxelM H Kang, W D Figg, Y Ando, et al.
Thescientificworldjournal|February 25, 2014
Angiogenesis in spontaneous tumors and implications for comparative tumor biologyC Benazzi, A Al-Dissi, C H Chau, et al.
Cancer Investigation|January 1, 1996
Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancerW D Figg, K Ammerman, N Patronas, et al.
Pharmacotherapy|December 17, 1998
Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virusS C Piscitelli, S Vogel, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanismsH R Alexander, C K Brown, D L Bartlett, et al.
Cancer|September 1, 1994
Acute renal toxicity associated with suramin in the treatment of prostate cancerW D Figg, M R Cooper, A Thibault, et al.
Journal of Clinical Pharmacology|April 1, 1995
Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamineS C Piscitelli, A Thibault, W D Figg, et al.
Pageof 14